David Mongan reports on a recent trial of omega-3 supplementation for the prevention of psychosis in people at ultra-high risk, which finds no evidence of a positive effect. He reflects on these findings and considers what’s next for the field.
[read the full story...]
Nicola Rizzo Pesci and Andrea Cipriani summarise findings from the EMERGENT-2 trial spotlighting a promising new drug treatment for schizophrenia.
[read the full story...]
Emanuele Osimo blogs about the 20-year follow up of the OPUS trial, which tested early intervention services for people with first-episode schizophrenia spectrum disorder.
[read the full story...]
Steven Parkes considers a randomised controlled trial exploring the satisfaction and side effects of gameChange, a virtual reality intervention targeting anxiety in every day situations for patients with psychosis.
[read the full story...]
In her debut blog, Jude Madani summarises the findings of the PRODIGY trial, which looked at the clinical and cost-effectiveness of social recovery therapy for the prevention and treatment of long-term social disability among young people with emerging severe mental illness.
[read the full story...]
Silke Vereeken summarises the INTERACT randomised controlled trial, which reports on the efficacy of Acceptance and Commitment Therapy in daily life for people with early psychosis.
[read the full story...]
Imogen Bell summarises the gameChangeVR trial of virtual reality for agoraphobic avoidance and distress in patients with psychosis.
[read the full story...]
Imogen Bell blogs about a recent randomised controlled trial of the SlowMo app, which aimed to slow down thinking patterns and correct interpretation biases in people experiencing paranoia.
[read the full story...]
Dave Steele summarises a recent randomised controlled trial, which suggests that there may be benefit in self-stigma programmes for those with severe mental illness, but more work is needed.
[read the full story...]
A group of UCL Mental Health MSc students summarise a recent pilot study, which explores the acceptability and feasibility of the Texting for Relapse Prevention (T4RP) programme for people with schizophrenia or schizoaffective disorder.
[read the full story...]
